Hancock Jaffe Laboratories, Inc. Warrants
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Hancock Jaffe Laboratories, Inc. Warrants generated cash of -$7,677,210, which is less than the previous year. Cash used in financing activities reached the amount of $15,074,799 last year. Net change in cash is therefore $7,217,298.
Cash Flow
| 2015 | -2.01M | -77.62K | 3.62M |
|---|---|---|---|
| 2016 | -3.08M | -705.26K | 2.26M |
| 2017 | -4.20M | 165.31K | 4.05M |
| 2018 | -6.35M | -12.42K | 9.03M |
| 2019 | -5.89M | -363.89K | 5.63M |
| 2020 | -7.67M | -180.29K | 15.07M |
HJLIW Cash Flow Statement (2015 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 2.11M | 2.74M | 77.68K | 56.51K | 1.58M | 58.02K |
Operating activities | ||||||
Net income | -9.13K | -7.62M | -13.04M | -7.79M | -3.38M | -1.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 383.97K | 396.66K | 133.41K | 139.21K | 151.17K | 125.42K |
Stock-based compensation expense | 881.21K | 941.96K | 1.92M | 878.40K | 1.51M | 0 |
| Deferred income tax benefit | 881.21K | 941.96K | 1.92M | 878.40K | 1.51M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 32.02K | 3.15K | -11.68K | 309K | 25.24K |
Inventories | 0 | 0 | -217.03K | 90.90K | -213.17K | 171.90K |
Accounts payable | 169.17K | 144.06K | -294.12K | 545.38K | -76.32K | -83.53K |
Cash generated by operating activities | -7.67M | -5.89M | -6.35M | -4.20M | -3.08M | -2.01M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -180.29K | -363.89K | -12.42K | -10.93K | -373.61K | -2.62K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -180.29K | -363.89K | -12.42K | 165.31K | -705.26K | -77.62K |
Financing activities | ||||||
Common Stock Issued | 10.41M | 5.63M | 7.65M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.24M | 0 | -186.62K | 0 |
Cash used in financing activities | 15.07M | 5.63M | 9.03M | 4.05M | 2.26M | 3.62M |
Net Change In Cash | 7.21M | -623.35K | 2.66M | 21.17K | -1.52M | 1.52M |
Cash at end of period | 9.33M | 2.11M | 2.74M | 77.68K | 56.51K | 1.58M |
| Data source | Data source | Data source |